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Abstract  
The synthesis and bioactivity of gold nanoparticles has been extensively studied. However, the antibacterial activity of gold 
nano particles individually or in combination with different antibiotics has not been demonstrated. In the present study the 
effect of gold nano particles on the antibacterial activity of different antibiotics was evaluated against Staphylococcus aureus, 
k.pnemonea, P.aureginosa, E.coli. Disk diffusion method was used to determine the antibacterial activity of various antibiotics 
in the absence and presence of sub inhibitory concentration of gold nano particles. A clinical isolates of S. aureus, 
k.pnemonea, p.aureginosa,E.coli. were used as the test strains. In the presence of sub-inhibitory concentration of gold nano 
particles the antibacterial activities of all antibiotics have. Increased from minimum 2 mm to a maximum of 8 mm. The highest 
increase was observed for ceftazidime followed by genthamycin. These results signify that the gold nano particles potentiate 
the antimicrobial action of cephalosporins and amino glycosides, suggesting a possible utilization of nano compounds in 
combination therapy against S. aureus, k.pnemonea, p.aureginosa,E.coli. 
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INTRODUCTION 
 
     The development of reliable, eco-friendly processes for the 
synthesis of nanomaterials is an important aspect of nanotechnology 
today. One approach that shows immense potential is based on the 
biosynthesis of nanoparticles using biological micro-organisms such 
as bacteria.  
     Most of the natural processes also take place in the 
nanometer scale regime. Therefore, a confluence of nanotechnology 
and biology can address several biomedical problems, and can 
revolutionize the field of health and medicine [1]. Biological 
methods are regarded as safe, cost-effective, sustainable and 
environment friendly processes for the synthesis of nanoparticles. 
     Gold nanoparticles have been successfully synthesized using 
various Bacteria (2), Fungi 3. 
     Over the recent decade, gold nanoparticles (NPs) [4] have 
attracted significant interest as a novel platform for various 
applications such as nanobiotechnology and biomedicine [5–7] 
because of convenient surface bioconjugation [8] with molecular 
probes and remarkable plasmon- resonant optical properties [9]. 
Recently published examples include applications of NPs to 
biosensorics [10], genomics [11,12], clinical chemistry [13], 
immunoassays [14], immune response enhancement [15], detection 
and  control of microorganisms [16], and targeted delivery of drugs 
or genetic and immunological substances [17].Conjugates of gold 
NPs with antibiotics and antibodies also have been used for selective 
photothermal killing of protozoa and bacteria [18]. The development 
of new resistant strains of bacteria to current antibiotics  (19) has 
become a serious problem in public health; therefore, there is a 
strong incentive to develop new bactericides [20].  
     The emergence of bacterial resistance to antibiotics and its 
dissemination, however, are major health problems, leading to 
treatment drawbacks for a large number of drugs [21, 22]. 
Consequently there has been increasing interest in the use of 
inhibitors of antibiotic resistance for combination therapy [23-24]. 
Investigations have been carried out on the biological activities of 
gold  nano particles; however, the effects of nano-particles on the 
activities of antibiotics have not been demonstrated.  
     In the present study, gold nanoparticles are synthesized using 
Baccillus sp. The study deals with the effect of biologically 
synthesized gold nanoparticles and effect on gold nano particles on 
the antibacterial activity of different antibiotics was evaluated against 
Staphylococcus aureus, k.pnemonea, P.aureginosa, E.coli . 
 
MATERAILS AND METHODS 
Preparation of Gold Nano Particles 
 
     Gold nano particles were synthesized by usingt bacillus sp. 
These gold nano particles were used to test the antibacterial activity 
as well as synergistic effect on antibiotis action against pathogenic 
bacteria Staphylococcus aureus, k.pnemonea, P.aureginosa, E.coli .  
 
Microbial Assay Gold Nano Particles 
 
     Antibacterial activity of gold nano particles were studied by 
the agar-well-diffusion method, wherein a bacterial suspension was 
added to sterile nutrient agar at 45 _C and the mixture was solidified 
on a Petri dish. A 20-mL volume of the medium was poured into a 
Petri dish (diameter, 90 mm) on a horizontally leveled surface. After 
the medium had solidified, 6-mm-diameter wells were made in the 
agars (at six wells per dish) that were equidistant from one another 
and from the dish edge. The wells received either 0,25, 35, 45 55 
and 100µl of gold nano particles and equal volumes of the free 
antibiotic solution and NP mixture. The Petri dishes were incubated 
in a thermostat at 37OC for 24 h. After incubation, the diameter of the 
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zone of bacterial-growth inhibition was measured with an accuracy of 
±0.1 mm. The mean inhibition-zone diameter were determined. All 
experiments were repeated thrice. 
 
Antibacterial assay 
 
     A clinical isolates of S. aureus  k.pnemonea, p.aureginosa, 
E.coli. were obtained from the MTCC . The disk diffusion method 
was used to assay the activity of 4 different antibiotics against test 
strains on Mueller-Hinton agar (Hi Media, INDIA) plates according to 
the CLSI [25]. The standard antibiotics disks were procured from Hi 
Media. To determine combined effects, each standard paper disc 
was further impregnated with sub-inhibitory concentration of gold 
nano particles. A single colony of test strains was grown overnight in 
Mueller -Hinton broth on a rotary shaker (200 rpm) at 35°C. The 
inoculums were prepared by diluting the overnight cultures with 0.9% 
NaCl to a 0.5 McFarland standard. A lawn of the test organism was 
made on the agar plate using a sterile cotton swab and the antibiotic 
discs and gold nanoparticles separately (with and without gold nano 
particles) were placed on the bacterial lawn. After incubation at 37°C 
for 24 hrs, the zones of inhibition were measured. The assays were 
performed in triplicate. 
 
RESULTS AND DISCUTION 
 
     Therapeutic roles for gold in different diseases have been 
established in recent years. Gold oxide has a very good potential to 
move into the clinic [26]. In this investigation the effect of gold nano 
particles on the antibacterial properties of different antibiotics was 
investigated against S. aureus, K. pnemonea, P. aureginosa, 
E.coli .using the disk diffusion method.  
     The synergetic effect of the Gold nano-particles as observed 
by the increase in diameter of inhibition zones (mm) around the 
different antibiotic disks with gold nano-particles have been recorded 
in respect of certain antibiotics [Table-1]. The activities of all the 
antibiotics have increased in the presence of nanosize gold particles 
against the test strains.  
     The effect of gold nano particles were investigated against S. 
aureus , k.pnemonea, P.aureginosa, E.coli . Table 2 shows The 
inhibitory activity were more aginest S.aureus compared to S. 
aureus , K. pnemonea, P.aureginosa, E.coli.
 
Table 1. Synergistic effect of gold nano particles on Antibacterial activity of antibiotics against bacteria 
 
S.No Antibiotic S.aureus K.pnemoniae P.aureginosa E.coli 
Ab only 
(mm) 
With nano 
gold(mm) 
Ab only (mm) With nano 
gold(mm) 
Ab only 
(mm) 
With nano 
gold(mm) 
Ab only 
(mm) 
With nano 
gold(mm) 
1 Genthamycin 28 31 24 28 31 38 18 22 
2 Ceftazidime 28 30 32 37 21 25 20 28 
3 Vancomycin 13  00  00  09  
4 Methicillin 00  00  00  06  
 
Table 2. Antibacterial activity of gold nano particles 
 
S.No Concentration (µl) S.aureus (mm) K.pnemoniae (mm) P.auriginosa (mm) E.coli (mm) 
1 Controle 00 00mm 00mm 00mm 
2 25 10 09 10 08 
3 35 14 12 11 09 
4 45 16 13 14 12 
5 55 19 15 15 15 
6 100 23 19 20 20 
     Anti bacterial study indicates that antibiotic + gold nano 
particles Sythesized by  Baccillus sp  exhibit more zone of 
inhibition compared to standard antibiotics  used (Table 1). The 
zone of inhibition on E.coli , k.pnemonea, P.aureginosa  were  
more when compared with the zone of inhibition exhibited on 
S.aureus. The biosynthesized gold nanoparticles with the antibiotic  
ceftazidime [30mm, 37mm, 25mm and 28mm] exhibit high zone of 
inhibition as compared with genthamycin [ 31mm, 28mm, 38mm and 
22mm]. the  synergistic activity of biosynthesized gold 
nanoparticles were more against gram negative bacteria compaired 
to gram positive (table no 1). The highest increases in the inhibition 
zones were observed for  ceftazidime (4-8 mm) than the 
genthamycine (3-7mm) 
     Gold nano particle showed no synergetic effect on the 
antibacterial activity against the test strain. It should be pointed out 
that the gold nano particles content of 100 µg/disc was chosen to 
guarantee that the effect produced was due to the combination and 
not to the effect of the gold nano particles itself (18-22). So the effect 
observed in this condition could be due to the antibiotic-gold nano 
particles combination. At the concentration tested, gold nano particle 
significantly Improved antibiotic efficacy against S. aureus, 
k.pnemonea, P.aureginosa, E.coli when combined with antibiotics . 
At this time the reason of these enchantments and the reason for 
these differences are not known and merits investigation. Efflux 
transporter mediated bacterial resistance to different antibiotics and 
gold nano particles may inhibit this efflux pump system [27].  
     Comparison of these data with the findings in the literature 
[28, 29, 30], showing enhancement of antibacterial activity in the 
presence of NPs, suggests that two conditions at minimum are 
necessary (but insufficient) for such effects to be observed. First, 
antibiotic–NP conjugates should be stabilized, and their spectrum 
and color should correspond to those of single-particle non 
aggregated colloids. Second, the amount of the antibiotic covering 
the particle surface should be large enough to ensure an increase in 
the local antibiotic concentration at the site of bacterium–particle 
contact. 
 
CONCLUSION 
 
     The biosynthesis of nano size gold particles was carried out 
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successfully using bacillus sp. The small nanometer scale gold 
particles which enhanced activity of several antibiotics. Further work 
is needed to find out the exact reasons for enhancement of activity of 
antibiotics in presence of gold nano particles. 
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